Tuesday, 16 September 2014
Last updated 3 sec ago
Apr 8 2013 | 9:50am ET
Cantab Capital Partners, the $5.3 billion systematic global macro manager led by former Goldman Sachs quantitative trader Ewan Kirk, has named two new partners.
Matthew Killeya (senior scientist) and Genia Diamond (head of business development), have been named partners in recognition of their contribution to Cantab's success.
Diamond has led Cantab's investor relations team since 2011, during which period the firm's assets have increased fivefold. Diamond joined Cantab from OMAM UK, prior to which she was at Solent Capital and BlueCrest Capital. She started her career in asset management as a senior hedge fund researcher at PAAMCO.
Killeya works on all aspects of program and portfolio construction and has recently been focused on short-term execution algorithms and strategies to trade options as a diversifier to futures strategies.Prior to joining Cantab, Killeya spent five years as a senior managing researcher at Winton Capital Management.
Said Kirk in a statement: “Our investors know that we take both our investment models and investor relations immensely seriously. Both Genia and Matthew have contributed significantly to these respective functions, as well as the overall development of Cantab. As a result we are truly pleased they have accepted our offer to join the partnership”
Based in Cambridge, UK, Cantab Capital Partners was founded in 2006 by Kirk, his fellow Goldman alumnus Erich Schlaikjer and KBC vet Chris Pugh. Tom Howat became a Partner in 2011.
Aug 25 2014 | 11:21am ET
As many of you know, FINalternatives was recently acquired by the owners of Futures magazine, a firm called The Alpha Pages LLC. Today marks the soft-launch of a new sister site for both publications. As its name suggests, The Alpha Pages will cover all types of alternative investments, going far beyond the more well-known ones such as hedge funds and private equity. Read more…
The Federal Reserve keeps baby-stepping toward a “normalization” of monetary policy. But just what is normal?